Werner Kramer - Publications, H-index & Citations

Werner Kramer

CEA

46H指数

173论文数

6.0K被引数

收录论文 33

发表时间

Fostering improved human islet research: a European perspective

DIABETOLOGIA

IF10.2

2019-06-13

OAAI

Marchetti, Piero; Schulte, Anke M.; Marselli, Lorella; Schoniger, Eyke; Bugliani, Marco; Kramer, Werner; Overbergh, Lut; Ullrich, Susanne; Gloyn, Anna L.; Ibberson, Mark; Rutter, Guy; Froguel, Philippe; Groop, Leif; McCarthy, Mark I.; Dotta, Francesco; Scharfmann, Raphael; Magnan, Christophe; Eizirik, Decio L.; Mathieu, Chantal; Cnop, Miriam; Thorens, Bernard; Solimena, Michele

Insulin translates unfavourable lifestyle into obesity

BMC MEDICINE

IF8.3

2018-12-13

OAAI

Kolb, Hubert; Stumvoll, Michael; Kramer, Werner; Kempf, Kerstin; Martin, Stephan

Plasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans

CELL REPORTS

IF6.9

2017-02-01

180

OAAI

Wigger, Leonore; Cruciani-Guglielmacci, Celine; Nicolas, Anthony; Denom, Jessica; Fernandez, Neike; Fumeron, Frederic; Marques-Vidal, Pedro; Ktorza, Alain; Kramer, Werner; Schulte, Anke; Le Stunff, Herve; Liechti, Robin; Xenarios, Ioannis; Vollenweider, Peter; Waeber, Gerard; Uphues, Ingo; Roussel, Ronan; Magnan, Christophe; Ibberson, Mark; Thorens, Bernard

Identification of novel inhibitors of the steroid sulfate carrier 'sodium-dependent organic anion transporter' SOAT (SLC10A6) by pharmacophore modelling

MOLECULAR AND CELLULAR ENDOCRINOLOGY

IF3.6

2016-06-01

OAAI

Grosser, Gary; Baringhaus, Karl-Heinz; Doering, Barbara; Kramer, Werner; Petzinger, Ernst; Geyer, Joachim

Pancreatic β-cell imaging in humans: fiction or option?

DIABETES OBESITY & METABOLISM

IF5.7

2015-10-05

OAAI

Laurent, D.; Vinet, L.; Lamprianou, S.; Daval, M.; Filhoulaud, G.; Ktorza, A.; Wang, H.; Sewing, S.; Juretschke, H. -P.; Glombik, H.; Meda, P.; Boisgard, R.; Nguyen, D. L.; Stasiuk, G. J.; Long, N. J.; Montet, X.; Hecht, P.; Kramer, W.; Rutter, G. A.; Hecksher-Sorensen, J.

Profiling of Energy Metabolism in Olanzapine-Induced Weight Gain in Rats and Its Prevention by the CB1-Antagonist AVE1625

OBESITY

IF4.7

2012-09-06

PREAI

Liebig, Michaela; Gossel, Matthias; Pratt, Jeremy; Black, Mark; Haschke, Guido; Elvert, Ralf; Juretschke, Hans-Paul; Neumann-Haefelin, Claudia; Kramer, Werner; Herling, Andreas W.

The peroxisome proliferator-activated receptor-α (PPAR-α) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats

ACTA PHARMACOLOGICA SINICA

IF8.4

2009-06-08

OAAI

Linz, Wolfgang; Wohlfart, Paulus; Baader, Manuel; Breitschopf, Kristin; Falk, Eugen; Schaefer, Hans-Ludwig; Gerl, Martin; Kramer, Werner; Ruetten, Hartmut

Induced release of membrane vesicles from rat adipocytes containing glycosylphosphatidylinositol-anchored microdomain and lipid droplet signalling proteins

CELLULAR SIGNALLING

IF3.7

2009-02-01

PREAI

Mueller, Guenter; Jung, Christian; Straub, Julia; Wied, Susanne; Kramer, Werner

Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed Wistar rats

ENDOCRINOLOGY

IF3.3

2008-02-14

OAAI

Herling, Andreas W.; Kilp, Susanne; Elvert, Ralf; Haschke, Guido; Kramer, Werner

Identification of target genes linking cholesterol and glycosphingolipid homeostasis to the pathophysiology of Niemann-Pick type C disease

CHEMISTRY AND PHYSICS OF LIPIDS

IF2.8

2007-09-01

PREAI

Orso, Evelyn; Wolf, Zsuzsanna; Leuthaeuser, Kerstin; Binder, Marion; Klunemann, Hans H.; Kramer, Werner; Schmitz, Gerd

Intestinal bile salt absorption in Atp8b1 deficient mice

JOURNAL OF HEPATOLOGY

IF33

2007-07-01

PREAI

Groen, Annemiek; Kunne, Cindy; Paulusma, Coen C.; Kramer, Werner; Agellon, Luis B.; Bull, Laura N.; Elferink, Ronald P. J. Oude

Pharmacological interference with hepatic glucose production

THE METABOLIC SYNDROME X: CONVERGENCE OF INSULIN RESISTANCE, GLUCOSE INTOLERANCE, HYPERTENSION, OBESITY, AND DYSLIPIDEMIAS-SEARCHING FOR THE UNDERLYING DEFECTS

IF0

2006-02-06

PREAI

Burger, HJ; Schubert, G; Hemmerle, H; Kramer, W; Herling, AW

Correlation between insulin resistance and intramyo cellular lipid levels in rats

MAGNETIC RESONANCE IN MEDICINE

IF3

2005-05-19

OAAI

Kulhmann, J; Neumann-Haefelin, C; Belz, U; Kramer, W; Juretschke, HP; Herling, AW

Aminopeptidase N (CD13) is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush border membrane

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2005-01-01

113

OAAI

Kramer, W; Girbig, F; Corsiero, D; Pfenninger, A; Frick, W; Jähne, G; Rhein, M; Wendler, W; Lottspeich, F; Hochleitner, EO; Orsó, E; Schmitz, G

Muscle-type specific intramyocellular and hepatic lipid metabolism during starvation in Wistar rats

DIABETES

IF7.5

2004-03-01

OAAI

Neumann-Haefelin, C; Beha, A; Kuhlmann, J; Belz, U; Gerl, M; Quint, M; Biemer-Daub, G; Broenstrup, M; Stein, M; Kleinschmidt, E; Schaefer, HL; Schmoll, D; Kramer, W; Juretschke, HP; Herling, AW

Intestinal cholesterol absorption:: identification of different binding proteins for cholesterol and cholesterol absorption inhibitors in the enterocyte brush border membrane

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

IF3.3

2003-07-01

PREAI

Kramer, W; Girbig, F; Corsiero, D; Burger, K; Fahrenholz, F; Jung, C; Müller, G

Synthesis of a biotin-tagged photoaffinity probe of 2-azetidinone cholesterol absorption inhibitors

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2003-04-01

PREAI

Frick, W; Bauer-Schäfer, A; Bauer, J; Girbig, F; Corsiero, D; Heuer, H; Kramer, W